Nasal administration of desmopressin
US5763398A · kind A · utility
37Cited by
13References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 20, 1996 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Jun 20, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for single, effective and consistent plasma level, nasal administration of an aqueous solution of from about 5 to about 75 .mu.l and from about 0.2 to about 2.0 mg/ml of desmopressin acetate, a molarly corresponding amount of desmopressin or a pharmaceutically acceptable salt: of desmopressin. The composition is useful for the management of urinary disorders such as diabetes insipidus, incontinence, and nocturnal enuresis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.